We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
-2.55%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+510.85%
AUM
$305B
AUM Growth
-$14.4B
Cap. Flow
-$4.27B
Cap. Flow %
-1.4%
Top 10 Hldgs %
16.09%
Holding
4,031
New
127
Increased
1,527
Reduced
2,081
Closed
148

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$433M
2
LRCX icon
Lam Research
LRCX
+$373M
3
PFE icon
Pfizer
PFE
+$354M
4
VZ icon
Verizon
VZ
+$341M
5
EA
Electronic Arts
EA
+$305M

Sector Composition

Rank Sector Weight
1 Technology 23.18%
2 Healthcare 10.69%
3 Financials 10.58%
4 Industrials 8.45%
5 Consumer Discretionary 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCUT icon
2426
Lifetime Brands
LCUT
$220M
$3.78M ﹤0.01%
671,229
-2,049
-0.3% -$12.4K
ITCI
2427
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.78M ﹤0.01%
72,520
-5,200
-7% -$303K
VCYT icon
2428
Veracyte
VCYT
$3.42B
$3.78M ﹤0.01%
169,089
-5,010
-3% -$129K
LEGN icon
2429
Legend Biotech
LEGN
$3.93B
$3.77M ﹤0.01%
56,147
+19,889
+55% +$1.38M
RELY icon
2430
Remitly
RELY
$5.39B
$3.77M ﹤0.01%
149,446
-4,479
-3% -$101K
FLWS icon
2431
1-800-Flowers.com
FLWS
$261M
$3.75M ﹤0.01%
535,949
-63,814
-11% -$479K
EGBN icon
2432
Eagle Bancorp
EGBN
$877M
$3.75M ﹤0.01%
174,740
-3,405
-2% -$82.8K
BDJ icon
2433
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.75B
$3.74M ﹤0.01%
491,811
-15,124
-3% -$121K
PMT
2434
PennyMac Mortgage Investment
PMT
$828M
$3.74M ﹤0.01%
301,242
-29,726
-9% -$389K
STGW icon
2435
Stagwell
STGW
$2.28B
$3.73M ﹤0.01%
795,157
+170,930
+27% +$1.01M
CHCT
2436
Community Healthcare Trust
CHCT
$433M
$3.72M ﹤0.01%
125,356
-108,632
-46% -$3.65M
TVTX icon
2437
Travere Therapeutics
TVTX
$5.79B
$3.72M ﹤0.01%
415,834
+132,394
+47% +$1.87M
BHE icon
2438
Benchmark Electronics
BHE
$2.89B
$3.71M ﹤0.01%
152,972
-9,026
-6% -$229K
PDFS icon
2439
PDF Solutions
PDFS
$2.13B
$3.71M ﹤0.01%
114,372
+11,261
+11% +$431K
SEDG icon
2440
SolarEdge
SEDG
$1.98B
$3.7M ﹤0.01%
28,573
+2,407
+9% +$462K
CBZ icon
2441
CBIZ
CBZ
$2.96B
$3.68M ﹤0.01%
70,957
-12,829
-15% -$691K
ESTC icon
2442
Elastic
ESTC
$8.94B
$3.68M ﹤0.01%
45,298
+69
+0.2% +$4.7K
NABL icon
2443
N-able
NABL
$695M
$3.67M ﹤0.01%
284,509
+48,726
+21% +$664K
NVG icon
2444
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.69B
$3.66M ﹤0.01%
355,222
-79,591
-18% -$897K
FIZZ icon
2445
National Beverage
FIZZ
$2.93B
$3.66M ﹤0.01%
77,815
-6,253
-7% -$315K
IFLN
2446
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
$3.65M ﹤0.01%
213,817
+47,942
+29% +$833K
SHYD icon
2447
VanEck Short High Yield Muni ETF
SHYD
$456M
$3.64M ﹤0.01%
168,571
-195
-0.1% -$4.3K
HRMY icon
2448
Harmony Biosciences
HRMY
$2.24B
$3.62M ﹤0.01%
110,387
+1,665
+2% +$57.8K
PLOW icon
2449
Douglas Dynamics
PLOW
$967M
$3.61M ﹤0.01%
119,706
-6,405
-5% -$196K
SCHQ
2450
Schwab Long-Term US Treasury ETF
SCHQ
$798M
$3.61M ﹤0.01%
118,086
+104,400
+763% +$3.56M

Similar funds

Ameriprise's Q3 2023 Portfolio in Review

As of Q3 2023, Ameriprise held 4,031 positions worth $305B, down 4.5% from $319B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ameriprise's Q3 2023 filing shows 127 new, 1,527 increased, 2,081 reduced and 148 closed positions. Its largest new stake was TKO Group: 772,651 shares worth $64.9M. The largest sale was Johnson & Johnson, an estimated $433M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Ameriprise's largest Q3 2023 buy was TKO Group: 772,651 shares worth $64.9M.
  • Ameriprise added most to AT&T in Q3 2023, an estimated $501M increase.
  • Ameriprise's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $433M.
  • Ameriprise fully exited NiSource Inc. Series A Corporate Units in Q3 2023, selling an estimated $73.8M.
  • Ameriprise's ten largest holdings make up 16% of its $305B portfolio in Q3 2023.
  • Ameriprise opened 127 new positions and closed 148 in Q3 2023.
  • Ameriprise's portfolio value fell 4.5% quarter-over-quarter to $305B.

Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.